Asia-Pacific Digital Respiratory Device Market Analysis, 2020

COVID-19 Pandemic and Chronic Respiratory Diseases Promulgating Digital Respiratory Device Market in Asia-Pacific

Asia-Pacific Digital Respiratory Medical Device Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Asia-Pacific Digital Respiratory Device Market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

COVID-19 to Give Massive Boost to Digital Respiratory Device Market in the Asia Pacific

The sudden breakout of the COVID-19 pandemic in China and its spill-over to the other countries in the Asia-Pacific has induced the demand for Digital Respiratory Medical Devices at an exponential rate. The rise in death toll and the number of infected individuals would push the governments and private healthcare players toward the adoption of more sophisticated respiratory medical devices used in the detection, prevention, and monitoring of such viral pandemics. Therefore, the demand is expected to proliferate in the forthcoming years as the precautionary healthcare spending in all the countries is set to snowball to a considerable extent.

According to this research report titled “Asia Pacific Digital Respiratory Device Market Analysis, 2020”, the Asia-Pacific Digital Respiratory Device Market is anticipated to grow at a CAGR of around 30% during 2020-25. Due to the advent of new technological advancements in emerging economies coupled with bolstering public awareness the healthcare expenditure has been increasing. Also, the surging use of digital medical technology and devices by patients is expected to further escalate the demand for digital respiratory medical devices market in the Asia-Pacific region.

Increasing Chronic Respiratory Diseases is Amplifying the Growth in the Region

COVID-19 has suddenly shocked the economies in the APAC region where the healthcare infrastructure is not comparable to the global benchmarks. The sudden surge of the pandemic has increased the patients suffering from respiratory ailments. China is considered has the largest number of incidences of chronic obstructive pulmonary diseases owing to the rising aging population. As of Jan 2020, around 41.3% population in China and the Province of China were aged over 60 years of age according to United National (UN). Owing to alarming levels of air pollution, exposure to chemicals, aging population, rising smoking habit in inhabitants, etc., the rate of frequency of diseases such as chronic pulmonary diseases (COPD) and asthma is growing among the population in the region. Therefore, the therapeutic devices segment is leading the market by the largest market share as stated in the research report “Asia-Pacific Digital Respiratory Device Market Analysis, 2020”.

India Showing Progressive Growth in the Region

Among India’s 1.31 billion people, about 6% of children and 2% of adults have asthma. Due to rapid urbanization and continuous increasing population awareness, the usage of digital medical devices has increased over the years. Moreover, with the widespread presence of other respiratory diseases, such as chronic bronchitis, emphysema, and COPD, the Indian government is taking initiatives to mitigate the respiratory ailments with improving medical facilities in the country.

According to the publisher, the key players with a considerable market share in the Asia-Pacific Digital Respiratory Device Market include Philips, 3M Healthcare, Astra Zeneca Plc., Novartis AG, GE Healthcare, Masimo Corporation, Cipla Ltd., Resmed Ltd., Teva Pharmaceuticals Industries Ltd., Acorda Therapeutics, etc.

Key Questions Answered in the Market Research Report

1. What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Asia-Pacific Digital Respiratory Device Market?
2. What are the region-wise industry size, growth drivers and challenges key market trends?
3. What are the key innovations, technology upgrades, opportunities, regulations in the Asia-Pacific Digital Respiratory Device Market?
4. Who are the key competitors or market players and how they perform in the Asia-Pacific Digital Respiratory Device Market based on a competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the Asia-Pacific Digital Respiratory Device Market study?

1. Introduction

1.1. Product Definition
1.2. Research Process
1.3. Glossary
1.4. Market Segmentation

2. Executive Summary3. Expert Verbatim- Interview Excerpts of Industry Experts

4. Asia-Pacific Digital Respiratory Device Market Outlook, 2015-2025F

4.1. Market Size & Analysis
4.1.1. By Units Sold
4.1.2. By Revenues
4.2. Market Share & Analysis
4.2.1. By Product
4.2.1.1. Therapeutic Devices
4.2.1.1.1. CPAP Devices
4.2.1.1.2. BI-PAP Devices
4.2.1.1.3. Humidifiers
4.2.1.1.4. Nebulizers
4.2.1.1.5. Ventilators
4.2.1.1.6. Inhalers
4.2.1.1.7. Oxygen Concentrates
4.2.1.1..8. Resuscitators
4.2.1.2. Diagnostics Monitoring Devices
4.2.1.2.1. Spirometers
4.2.1.2.2. Pulse Oximeters
4.2.1.3. Consumables and Accessories
4.2.1.4. Respiratory Therapy Wearable Medical Device
4.2.1.4.1. Watch and Wristband
4.2.1.5. Disposables
4.2.1.5.1. Nasal Cannulas
4.2.1.5.2. Filters
4.2.1.5.3. Breathing Circuits
4.2.2. By End-User
4.2.2.1. Homecare
4.2.2.2. Hospitals and Clinics
4.2.2.3. Ambulatory Care Centers
4.2.3. By Indication
4.2.3.1. Chronic Obstructive Pulmonary Disease
4.2.3.2. Sleep Apnea
4.2.3.3. Asthma
4.2.3.4. Infectious Disease
4.2.4. By Country
4.2.4.1. China
4.2.4.2. India
4.2.4.3. Japan
4.2.4.4. Australia
4.2.4.5. New Zealand
4.2.4.6. South Korea
4.2.4.7. Rest of Asia-Pacific
4.2.5. By Company
4.2.5.1. Revenue Shares
4.2.5.2. Strategic Factorial Indexing
4.2.5.3. Competitor Placement in MarkNtel Quadrant

5. Asia Pacific Digital Respiratory Medical Device Market Outlook, 2015-2025F

5.1. Market Size & Analysis
5.1.1. By Units Sold
5.1.2. By Revenue
5.2. Market Share & Analysis
5.2.1. By Product Type
5.2.2. By End-User
5.2.3. By Application
5.3. China Digital Respiratory Medical Device Market Outlook, 2015-2025F
5.3.1. Market Size & Analysis
5.3.1.1. By Units Sold
5.3.1.2. By Revenues
5.3.2. Market Share & Analysis
5.3.2.1. By Product
5.3.2.2. By End-User
5.3.2.3. By Application
5.4. India Digital Respiratory Medical Device Market Outlook, 2015-2025F
5.4.1. Market Size & Analysis
5.4.1.1. By Units Sold
5.4.1.2. By Revenues
5.4.2. Market Share & Analysis
5.4.2.1. By Product
5.4.2.2. By End-User
5.4.2.3. By Application
5.5. Japan Digital Respiratory Medical Device Market Outlook, 2015-2025F
5.5.1. Market Size & Analysis
5.5.1.1. By Units Sold
5.5.1.2. By Revenues
5.5.2. Market Share & Analysis
5.5.2.1. By Product
5.5.2.2. By End-User
5.5.2.3. By Application
5.6. Australia Digital Respiratory Medical Device Market Outlook, 2015-2025F
5.6.1. Market Size & Analysis
5.6.1.1. By Units Sold
5.6.1.2. By Revenues
5.6.2. Market Share & Analysis
5.6.2.1. By Product
5.6.2.2. By End-User
5.6.2.3. By Application
5.7. New Zealand Digital Respiratory Medical Device Market Outlook, 2015-2025F
5.7.1. Market Size & Analysis
5.7.1.1. By Units Sold
5.7.1.2. By Revenues
5.7.2. Market Share & Analysis
5.7.2.1. By Product
5.7.2.2. By End-User
5.7.2.3. By Application
5.8. South Korea Digital Respiratory Medical Device Market Outlook, 2015-2025F
5.8.1. Market Size & Analysis
5.8.1.1. By Units Sold
5.8.1.2. By Revenue
5.8.2. Market Share & Analysis
5.8.2.1. By Product
5.8.2.2. By End-User
5.8.2.3. By Application
5.9. Rest of Asia-Pacific Digital Respiratory Medical Device Market Outlook, 2015-2025F
5.9.1. Market Size & Analysis
5.9.1.1. By Units Sold
5.9.1.2. By Revenues
5.9.2. Market Share & Analysis
5.9.2.1. By Product
5.9.2.2. By End-User
5.9.2.3. By Application

6. Asia-Pacific Digital Respiratory Device Dynamics

6.1. Drivers
6.2. Challenges
6.3. Impact Analysis

7. Asia-Pacific Digital Respiratory Device Regulations, Product Standards8. Asia-Pacific Digital Respiratory Device Value Chain Analysis9. Asia-Pacific Digital Respiratory Device Intellectual Property Rights Analysis10. Asia-Pacific Digital Respiratory Device Hotspots & Opportunities

11. Competition Outlook

11.1. Competitor Wise Growth Strategies
11.1.1. Product Portfolio
11.1.2. Brand Specialization
11.1.3. Target Markets
11.1.4. Research & Development
11.1.5. Strategic Alliances & Initiatives
11.2. Company Profiles
11.2.1. Philips
11.2.2. 3M Healthcare
11.2.3. Astra Zenca Plc.
11.2.4. Novartis AG
11.2.5. GE Healthcare
11.2.6. Masimo Corporation
11.2.7. Cipla Ltd.
11.2.8. Resmed Ltd.
11.2.9. Teva Pharmaceuticals Industries Ltd.
11.2.10. Acorda Therapeutics

12. Disclaimer